Teva Pharmaceutical Industries Ltd. has begun the commercial launch of escitalopram oxalate tablets, an antidepressant medication.


Teva Pharmaceutical Industries, escitalopram oxalate tablets, Lexapro, generic version of Lexapro, Forest Laboratories, marketing exclusivity, antidepressant, treatment of depression, generic medication


































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Teva ships generic of Lexapro

March 14th, 2012

JERUSALEM – Teva Pharmaceutical Industries Ltd. has begun the commercial launch of escitalopram oxalate tablets, an antidepressant medication.

Teva said Wednesday that its product is a generic version of Forest Laboratories' Lexapro Tablets.

Teva added that it has been awarded a 180-day period of marketing exclusivity for its product, since it was the first company to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for the generic medication.

Lexapro is indicated for the treatment of depression and generalized anxiety disorder. The branded product had annual U.S. sales of about $2.9 billion, based on IMS Health data cited by Teva.

 

Advertisement